Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells
MATER
1 other identifier
observational
101,000
1 country
1
Brief Summary
The MATER study is an observational cohort study on first ever transfusion recipients in six hospitals in the Netherlands, with information collected on both donor and patient characteristics. We aim to further specify which combination of characteristics of both donors and patients determine the increased risk of mortality after blood transfusions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
November 22, 2023
CompletedFirst Posted
Study publicly available on registry
December 19, 2023
CompletedDecember 19, 2023
March 1, 2019
1 year
November 22, 2023
December 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
In total, this cohort contains data on over 100,000 first-ever transfusion recipients and their received transfusions from six hospitals in the Netherlands, with information collected on both donor and patient characteristics.
2015-2018
Eligibility Criteria
First ever red blood cell transfusion recipients in the Netherlands between 20-03-2004 and 31-12-2018 which were performed in the hospitals participating in the R-FACT study will be included in this study. All blood donations and the corresponding donors linked to these recipients will be included in this study.
You may qualify if:
- have received a first transfusion between 20-03-2004 and 31-12-2018 in one of the hospitals participating in the R-FACT study OR
- have donated blood for a blood product which was used in one of the hospitals participating in the R-FACT study between 20-03-2004 and 31-12-2018
You may not qualify if:
- N.A.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sanquin blood bank
Amsterdam, 1066 CX, Netherlands
Related Publications (2)
Caram-Deelder C, Kreuger AL, Evers D, de Vooght KMK, van de Kerkhof D, Visser O, Pequeriaux NCV, Hudig F, Zwaginga JJ, van der Bom JG, Middelburg RA. Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients. JAMA. 2017 Oct 17;318(15):1471-1478. doi: 10.1001/jama.2017.14825.
PMID: 29049654BACKGROUNDMiddelburg RA, Briet E, van der Bom JG. Mortality after transfusions, relation to donor sex. Vox Sang. 2011 Oct;101(3):221-9. doi: 10.1111/j.1423-0410.2011.01487.x. Epub 2011 Apr 8.
PMID: 21477152BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
J van der Bom, Prof
Jon J van Rood Center for Clinical Transfusion Research
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2023
First Posted
December 19, 2023
Study Start
October 1, 2019
Primary Completion
October 1, 2020
Study Completion
October 1, 2020
Last Updated
December 19, 2023
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share